GPX4 and breast cancer: Another important finding was obtained by Yin et al. (2022) whose work highlighted the correlation between GPX4 inhibition and NCOA4-mediated ferritinophagy activation in tetrandrine citrate (TetC)-induced ferroptotic cell death in breast cancer (BC) cells.